Drug & pharmaceutical industry defensive for medicare bill – US

Major U.S. drug companies and pharmaceutical industry are coordinating a strategy to block legislation aimed at cutting drug prices in the country. These major players in drug industry met in Washington in the meeting of the Pharmaceutical Research and Manufacturers of America.

The US drug industry hopes to prevent the passage of a bill allowing Medicare to negotiate lower drug prices for those covered by its prescription program, and legislation allowing U.S. residents to buy prescription drugs in Canada.

Tactics might include hiring lobbyists with strong ties to Democrats and trying to get allies in Congress and in the Bush administration.

Pharmaceutical Researchers and Manufacturers of America (PhRMA) has said it would work with both political parties, it opposes government negotiation of Medicare prices saying that could limit drug choice. It also opposes drug imports from Canada and other countries.